Kevin Fitzgerald

Direttore Tecnico/Scientifico/R&S presso ALNYLAM PHARMACEUTICALS, INC.

Patrimonio netto: 5 M $ in data 31/08/2026

58 anni

Health Technology

Consumer Services

Questa pagina è riservata agli iscritti. Per continuare, accedi o crea un account.

Latest insider transactions

An executive increases exposure to an industrial stock

Sector rotation: insiders are more active on clean energy names

New regulatory filing published for executive transactions

Executive Management

Board of Directors

Audit Committee

Institutional Investors

Sell-side Analysts

2026 - Chairman of the Board

2022 - Chief Executive Officer

2018 - Chief Financial Officer

2012 - Strategy Committee Member